However, metastatic cancer is a serious risk as well. The authors of Reference 1 note there is evidence for both over-treatment and under-treatment, and more attention is needed to individualized therapy.
1. Lassmann M et al, “Dosimetry and thyroid cancer: the individual dosage of radioiodine”, Endocrine-Related Cancer 2010; 17:R161 – R172.
2. Radiation information from the Centers for Disease Control:
3. More information online:
Linda Fugate is a scientist and writer in Austin, Texas. She has a Ph.D. in Physics and an M.S. in Macromolecular Science and Engineering. Her background includes academic and industrial research in materials science. She currently writes song lyrics and health articles.